Reckitt Benckiser Shareholders: Important Class Action Alert for Investors
Reckitt Benckiser Shareholder Alert
In a significant development for shareholders of Reckitt Benckiser Group PLC, ClaimsFiler, a prominent shareholder information service, has issued a reminder regarding a pending class action lawsuit. Investors who have suffered losses exceeding $100,000 related to Reckitt's American Depositary Shares (ADSs) are encouraged to take action before the lead plaintiff application deadline on August 4, 2025.
This alert pertains to individual investors who acquired Reckitt's ADSs between January 13, 2021, and July 28, 2024, which marks the defined class period. This urgent notification follows claims that Reckitt and its executives failed to disclose crucial material information during the class period, breaching federal securities laws.
Details of the Lawsuit
The class action lawsuit alleges that Reckitt misled investors about the risks associated with its products, specifically the cow's milk-based infant formula, Enfamil. The issues raised include:
1. Increased Risk for Preterm Infants: Claims indicate that the product posed an increased risk of necrotizing enterocolitis (NEC) for preterm infants.
2. Impact on Sales: The potential health risks associated with the formula could significantly impact sales and lead to numerous legal claims.
3. Misleading Statements: Assertions made by the company regarding its business, operations, and future prospects were allegedly false and lacked reasonable foundation, causing investors to invest under false pretenses.
These allegations underscore serious concerns regarding Reckitt's transparency and corporate governance practices, as it pertains to the health and safety of vulnerable populations, such as infants.
Legal Proceedings
The lawsuit is filed in the United States District Court for the Southern District of New York, under the title Elevator Constructors Union Local No. 1 Annuity 401(K) Fund v. Reckitt Benckiser Group PLC, et al., No. 25-cv-4708. The legal proceedings aim to hold the company accountable for the alleged misconduct and to seek restitution for the affected shareholders.
Claim Your Rights
Reckitt Benckiser investors who believe they qualify for the class action are advised to visit ClaimsFiler or can reach out by calling toll-free at (844) 367-9658. Legal representatives from Kahn Swick & Foti, LLC are available to provide consultations and assist with inquiries regarding potential claims.
By registering at ClaimsFiler.com, investors can manage their claims effectively, gaining access to pertinent information regarding various securities class actions as well as notifications about related cases that may affect their investments.
Conclusion
As the deadline for filing lead plaintiff applications approaches, it is crucial for eligible investors to act promptly. This lawsuit could represent a vital opportunity for justice and recovery for shareholders who have been adversely impacted by Reckitt's actions. With claims of severe negligence regarding infant health risks, the outcome could also have broader implications for Reckitt’s reputation and operational integrity.
In times of uncertainty, resources such as ClaimsFiler remain essential for retail investors aiming to navigate complex securities litigation and reclaim their rightful share of potential settlements.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.